Luye Pharma Group (OTCMKTS:LYPHF – Get Free Report) is anticipated to issue its resultson Saturday, August 29th. Analysts expect Luye Pharma Group to post earnings of $0.0074 per share and revenue of $465.3280 million for the quarter.
Luye Pharma Group Stock Performance
OTCMKTS:LYPHF opened at $0.27 on Thursday. The firm’s fifty day simple moving average is $0.25 and its 200 day simple moving average is $0.31. Luye Pharma Group has a twelve month low of $0.20 and a twelve month high of $0.33.
About Luye Pharma Group
Luye Pharma Group Ltd. is a China-based pharmaceutical company headquartered in Yantai, Shandong Province. Established in 1994, the company specializes in the research, development, manufacturing and marketing of a broad portfolio of medicaments and health-care products. Luye Pharma structures its operations across three main segments: innovative drugs, generic drugs and over-the-counter (OTC) health and wellness products. Through in-house R&D and strategic collaborations, the company aims to address unmet medical needs in both domestic and international markets.
The company’s product offerings encompass key therapeutic areas such as oncology, cardiovascular disease, gastroenterology and respiratory illnesses.
See Also
- Five stocks we like better than Luye Pharma Group
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Luye Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luye Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
